More Information on 'Pronacera Therapeutics'

About Pronacera Therapeutics
PRONACERA THERAPEUTICS SL is a biotechnology company based in Sevilla in harnessing the talent of our young researchers as an engine for the development of plant protection treatments. Apply the knowledge gained from our own research and contribute to the optimization of human health system are some milestones in the company dedicated to putting patients for their diseases or lack of treatments are impaired quality of life. The products and services offered are based on stabilization processes of cell death in aging applications, Photopheresis extracorporeal treatment or screening methods capable of regulating the dose and reduce the damage associated with quimioerápicos. PRONACERA THERAPEUTICS SL emerged as Spin Off Group of Physiology, Anatomy and Cell Biology at the University Pablo de Olavide whose origins date back to 2011. It has the know-how derived from the development of international protection patent P201331533 compounds on cell stabilizers apoptotic or ES2438617B1 on Method for screening and / or evaluation of the effectiveness of drugs for the treatment of mitochondrial diseases and MELAS syndrome. It also has extensive experience in the study of apoptosis, mitochondrial and lysosomal diseases.